Literature DB >> 18376570

[Epidemiology of HPV infections and cervical cancer in Apulia: a survey study and current data analysis].

D Martinelli1, M Chironna, S Tafuri, A Neve, G Caputi, R Prato, C Germinario, M Quarto.   

Abstract

HPV infection is common in sexually active women and is an important risk factor for cervical cancer. The aim of this article is to describe the prevalence of HPV infection, the incidence and the mortality rates for cervical cancer and adherence to screening programs in Apulia in the light of recent introduction of anti-HPV vaccines. The prevalence of HPV was evaluated testing biological samples from 1082 women. The 33% resulted positive for HPV (80% for high-risk genotypes and 20% for low-risk genotypes). The 59% of positive samples showed only a single viral type while 37% multiple genotypes. In Apulia, from 1998 to 2005, a total of 1849 women were hospitalized for cervical cancer with a decreasing trend; the 46% had exo cervical cancer; the 22% endocervical cancer, 29% cancer of cervix without specification and 3% infiltrating cervical cancer. The mortality rate was 1,5 x 100.000. Data from PASSI study regarding cervical cancer screening showed that 62% of Apulian women 25-64 years aged had a Pap smear and 54.7% get it every three years. The viral genotypes circulating in Apulia region are present in anti-HPV vaccines; this item could give information on their introduction together with actions to implement the adherence to screening program that results lower than international standard.

Entities:  

Mesh:

Year:  2007        PMID: 18376570

Source DB:  PubMed          Journal:  Ann Ig        ISSN: 1120-9135


  1 in total

1.  Prevalence and type distribution of human papillomavirus infection in women from North Sardinia, Italy.

Authors:  Andrea Piana; Giovanni Sotgiu; Paolo Castiglia; Stefania Pischedda; Clementina Cocuzza; Giampiero Capobianco; Vincenzo Marras; Salvatore Dessole; Elena Muresu
Journal:  BMC Public Health       Date:  2011-10-11       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.